The objective of the study was to assess the usefulness of magnetic resonan
ce (MR) imaging in distinguishing malignant from benign conditions in patie
nts with an abnormal uterine cavity. Fifty-four patients that were suspecte
d of having abnormal uterine cavities were retrospectively evaluated by usi
ng MR imaging. The diagnosis of an abnormal uterine cavity included a thick
ened endometrium, and/or a endometrial mass, and/or a submucosal mass. Thre
shold values to classify the uterine cavity as abnormal on sagittal T-2-wei
ghted images were >10 mm for premenopausal women and >5 mm for postmenopaus
al women. Malignancy was diagnosed when lesions invaded the myometrial/junc
tional zone, and/or lesion enhancement was lower than that of the adjacent
myometrium. The results found that histology confirmed 18 malignant and 37
benign lesions. Twelve of 15 endometrial carcinomas and 3 malignant mixed m
esodermal tumors (MMMT) were correctly characterized as malignant on enhanc
ed T-1-weighted images; whereas 6 of 15 endometrial carcinomas and 3 MMMT w
ere correctly characterized on T-2-weighted images. Thirty-four of 37 benig
n cases were correctly characterized as not malignant on enhanced T-1-weigh
ted images. One of 14 submucosal leiomyomas, one endometrial stromal metapl
asia, and one of ten pathologically normal endometria were misdiagnosed on
enhanced T-1-weighted images but were correctly diagnosed on T-2-weighted i
mages. The overall sensitivity, specificity, and accuracy for distinguishin
g malignant from benign central uterine masses were 83%, 92%, and 89% for e
nhanced T-1-weighted image, and 50%, 97%, and 82% for T-2-weighted image, r
espectively. We came to the conclusion that in diagnosing patients with abn
ormal uterine cavity, MR imaging may help differentiate malignant from beni
gn disorders, (C) 1999 Elsevier Science Inc.